Oral iron, Intravenous iron or discontinuation of therapy for older adults with treatment-unresponsive iron deficiency anaemia - a pilot randomised controlled trial.

Oral iron, Intravenous iron or discontinuation of therapy for older adults with treatment-unresponsive iron deficiency anaemia - a pilot randomised controlled trial

Oral iron supplementation is the most common treatment for anaemia but it does not improve anaemia for all people and there are associated side effects. Three broad treatment strategies are possible yet there is no evidence regarding effectiveness or cost-effectiveness for them. A pilot randomised controlled trial was undertaken to assess the feasibility of conducting a definitive comparative trial of the following three treatment options: 1) no treatment, 2) oral iron supplementation and 3) intravenous iron infusion.

HERU researchers involved with this research project: Paul McNamee

External Collaborators: Myint, P. (Other Applied Health Sciences, University of Aberdeen); Witham, M., Hands, K. (Ninewells Hospital Dundee); Lee, A. (Medical Statistics Team, University of Aberdeen).